Labeler · US market

Shilpa Medicare Limited

Shilpa Medicare Limited is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 4 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes63759

Active drugs2

Registrations4 active / 4

Packages4

Sole supplier of0 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Pemetrexed Disodium injection	rx	3	3	SUPPLYING
Bortezomib injection	rx	1	1	SUPPLYING

At a glance

TypeLabeler
Labeler codes63759
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations4
Packages4

Recent events

Shortages, recalls, and registration changes across all filing names.

Dec 8, 2020
RECALLRecall (Class II): Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, …
Dec 8, 2020
RECALLRecall (Class II): Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial, Cytotoxic …
Dec 8, 2020
RECALLRecall (Class II): Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytoto…
Dec 8, 2020
RECALLRecall (Class II): Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytoto…
Dec 8, 2020
RECALLRecall (Class II): Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distribute…
Dec 8, 2020
RECALLRecall (Class II): Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distribute…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.